Saad Khan, MD
Psychiatry · Saint Louis, MONPI 1093707218
Payments from drug & device makers
Across 971 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Lundbeck LLC$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$1K
- Neurocrine Biosciences, Inc.$1K
- Johnson & Johnson$973
- plus $8K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 82 | $1,431 |
| Lundbeck LLC | 84 | $1,349 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 83 | $1,343 |
| AbbVie(2 entities) | 86 | $1,278 |
| Neurocrine Biosciences, Inc. | 59 | $1,063 |
| Johnson & Johnson | 52 | $973 |
| Teva Pharmaceuticals USA, Inc. | 53 | $917 |
| Alkermes, Inc. | 62 | $899 |
| Vanda Pharmaceuticals Inc. | 60 | $875 |
| Sunovion Pharmaceuticals Inc. | 46 | $782 |
| Bausch Health US, LLC | 49 | $727 |
| Takeda Pharmaceuticals U.S.A., Inc. | 46 | $677 |
| Corium, LLC | 31 | $573 |
| Noven Therapeutics, LLC | 31 | $469 |
| Axsome Therapeutics, Inc. | 25 | $446 |
| Tris Pharma Inc | 24 | $376 |
| Ironshore Pharmaceuticals Inc. | 20 | $298 |
| Neos Therapeutics, LP | 14 | $245 |
| Validus Pharmaceuticals LLC | 4 | $237 |
| Eisai Inc. | 13 | $163 |
| Avanir Pharmaceuticals, Inc. | 8 | $128 |
| Idorsia Pharmaceuticals US Inc | 8 | $126 |
| Supernus Pharmaceuticals, Inc. | 5 | $104 |
| E.r. Squibb & Sons, L.L.C. | 4 | $85 |
| Shire North American Group Inc | 6 | $80 |
| Jazz Pharmaceuticals Inc. | 4 | $78 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Merck | 2 | $41 |
| Indivior Inc. | 3 | $41 |
| Almatica Pharma LLC | 2 | $24 |
| Alfasigma USA, Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $12 |
How this compares
$15,911 in reported general payments places this provider in the 90th percentile of 680 psychiatry providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Saint Louis
- Junaid SyedSaint Louis$8M
- Ricky MofsenSaint Louis$4.9M
- Charles ConwaySaint Louis$3.8M
- Mohd MalikSaint Louis$2.8M
- Vadim BaramSaint Louis$1.9M
- Adam SkySaint Louis$1.1M
- Mary KimmelSaint Louis$539K
- George GrossbergSaint Louis$521K
- Asif HabibSaint Louis$517K
- Eric LenzeSaint Louis$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.